PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.0348202329SupplS157-S170Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and futureTina Reinson, Ryan M. Buchanan, Christopher D. Byrnehttp://e-cmh.org/upload/pdf/cmh-2022-0348.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0348, http://e-cmh.org/upload/pdf/cmh-2022-0348.pdf
Clinical and Molecular Hepatology10.3350/cmh.2022.0362202329SupplS150-S156Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developmentsSang Bong Ahnhttp://e-cmh.org/upload/pdf/cmh-2022-0362.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0362, http://e-cmh.org/upload/pdf/cmh-2022-0362.pdf
Hepatology10.1002/hep.2273520084919-11Back to the future with noninvasive biomarkers of liver fibrosisIndra Neil Guhahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22735, https://onlinelibrary.wiley.com/doi/full/10.1002/hep.22735
Yearbook of Gastroenterology10.1016/s0739-5930(08)70228-920072007281-283The NAFLD Fibrosis Score: A Noninvasive System That Identifies Liver Fibrosis in Patients with NAFLDG.A. Makarhttps://api.elsevier.com/content/article/PII:S0739593008702289?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593008702289?httpAccept=text/plain
Current Pathobiology Reports10.1007/s40139-014-0061-z201424245-256Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future DirectionsDaniel L. Motola, Peter Caravan, Raymond T. Chung, Bryan C. Fuchshttp://link.springer.com/content/pdf/10.1007/s40139-014-0061-z.pdf, http://link.springer.com/article/10.1007/s40139-014-0061-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40139-014-0061-z
Clinical Liver Disease10.1002/cld.634201795125-130Hepatic fibrosis scores and serum biomarkers in pediatric hepatologyDaniel H. Leunghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.634, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.634/fullpdf
Liver Diseases10.1007/978-3-030-24432-3_362020427-441Noninvasive Biomarkers for Liver FibrosisGamal Shiha, Nasser Mousahttp://link.springer.com/content/pdf/10.1007/978-3-030-24432-3_36
Clinical Liver Disease10.1002/cld.636201796134-137Putting it all together: Noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in adults and childrenNaim Alkhourihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.636, https://onlinelibrary.wiley.com/doi/full/10.1002/cld.636
Metabolism Open10.1016/j.metop.2021.100158202213100158Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]David Bernstein, Alexander J. Kovalichttps://api.elsevier.com/content/article/PII:S2589936821000827?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2589936821000827?httpAccept=text/plain
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2023.03.0422023Noninvasive Assessment of Liver Fibrosis in NAFLDArun J. Sanyal, Laurent Castéra, Vincent Wai-Sun Wonghttps://api.elsevier.com/content/article/PII:S1542356523002665?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1542356523002665?httpAccept=text/plain